Merck Betting Up To $2B On China-Developed Cardio Drug

Pharmaceutical giant Merck & Co. Inc., advised by Gibson Dunn & Crutcher LLP and Covington & Burling LLP, said on Tuesday it has entered into an exclusive license agreement with Cooley...

Already a subscriber? Click here to view full article